AKT1 and gastric cancer: We predicted that the primary mechanism of action of SL in the treatment of GC is as follows: mediating PI3K-Akt, Ras, MAPK, and other signaling pathways to regulate the proliferation, apoptosis, migration, and angiogenesis of tumour cells, thus playing a role in the treatment of GC.